Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Regulation of MDM4 (MDMX) function by p76MDM2: a new facet in the control of p53 activity

Oncogene volume 29, pages 5935–5945 (2010)Cite this article

Subjects

Abstract

Under basal growth conditions, p53 function is tightly controlled by the members of MDM family, MDM2 and MDM4. The Mdm2 gene codes, in addition to the full-length p90MDM2, for a short protein, p76MDM2 that lacks the p53-binding domain. Despite this property and at variance with p90MDM2, this protein acts positively toward p53, although the molecular mechanism remains elusive. Here, we report that p76MDM2 antagonizes MDM4 inhibitory function. We show that p76MDM2 possesses intrinsic ubiquitinating and degrading activity, and through these activities controls MDM4 levels. Furthermore, the presence of p76MDM2 decreases the association of MDM4 with p53 and p90MDM2, and antagonizes p53 degradation by the heterodimer MDM4/p90MDM2. The p76MDM2-mediated regulation of MDM4 occurs in the cytoplasm, under basal growth conditions. Conversely, upon DNA damage, phosphorylation of MDM4Ser403 dissociates p76MDM2 and prevents MDM4 degradation. The overall negative control of MDM4 by p76MDM2 reflects on p53 function as p76MDM2 impairs MDM4-mediated inhibition of p53 activity. In agreement with the positive role of p76MDM2 toward p53, the p76MDM2/p90MDM2 ratio significantly decreases in a group of thyroid tumor samples compared with normal counterparts. Overall, these findings reveal a new mechanism in the control of p53 basal activity that may account for the distinct sensitivity of tissues to stress signals depending on the balance among MDM proteins. Moreover, these data suggest an oncosuppressive function for a product of the Mdm2 gene.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Bueso-Ramos CE, Manshouri T, Haidar MA, Yang Y, McCown P, Ordonez N et al. (1996). Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat 37: 179–188.

    Article  CAS  Google Scholar 

  • Chen L, Gilkes DM, Pan Y, Lane WB, Chen J . (2005). ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J 24: 3411–3422.

    Article  CAS  Google Scholar 

  • Cheng T-H, Cohen SN . (2007). Human MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops. Mol Cell Biol 27: 111–119.

    Article  CAS  Google Scholar 

  • Dimitriadi M, Poulogiannis G, Liu L, Bäcklund LM, Pearson DM, Ichimura K et al. (2008). p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours. Br J Cancer 99: 1144–1152.

    Article  CAS  Google Scholar 

  • Francoz S, Froment P, Bogaerts S, De Clercq S, Maetens M, Doumont G et al. (2006). Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc Natl Acad Sci USA 103: 3232–3237.

    Article  CAS  Google Scholar 

  • Gentiletti F, Mancini F, D'Angelo M, Sacchi A, Pontecorvi A, Jochemsen AG et al. (2002). MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts. Oncogene 21: 867–877.

    Article  CAS  Google Scholar 

  • Kawai H, Lopez-Pajares V, Kim MM, Wiederschain D, Yuan ZM . (2007). RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity. Cancer Res 67: 6026–6030.

    Article  CAS  Google Scholar 

  • Kawai H, Wiederschain D, Kitao H, Stuart J, Tsai KK, Yuan ZM . (2003). DNA damage-induced MDMX degradation is mediated by MDM2. J Biol Chem 278: 45946–45953.

    Article  CAS  Google Scholar 

  • LeBron C, Chen L, Gilkes DM, Chen J . (2006). Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. EMBO J 25: 1196–1206.

    Article  CAS  Google Scholar 

  • Li C, Chen L, Chen J . (2002). DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms. Mol Cell Biol 22: 7562–7571.

    Article  CAS  Google Scholar 

  • Linares LK, Hengstermann A, Ciechanover A, Müller S, Scheffner M . (2003). HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc Natl Acad Sci USA 100: 12009–12014.

    Article  CAS  Google Scholar 

  • Linke K, Mace PD, Smith CA, Vaux DL, Silke J, Day CL . (2008). Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ 15: 841–848.

    Article  CAS  Google Scholar 

  • Mancini F, Di Conza G, Moretti F . (2009a). MDM4 (MDMX) and its transcript variants. Curr Genomics 10: 42–50.

    Article  CAS  Google Scholar 

  • Mancini F, Di Conza G, Pellegrino M, Rinaldo C, Prodosmo A, Giglio S et al. (2009b). MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J 28: 1926–1939.

    Article  CAS  Google Scholar 

  • Mancini F, Moretti F . (2009). Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle 8: 3854–3859.

    Article  CAS  Google Scholar 

  • Marine JC, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G . (2006). Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 13: 927–934.

    Article  CAS  Google Scholar 

  • Marine JC, Lozano G . (2010). Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 17: 93–102.

    Article  CAS  Google Scholar 

  • Meulmeester E, Maurice MM, Boutell C, Teunisse AF, Ovaa H, Abraham TE et al. (2005). Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol Cell 18: 565–576.

    Article  CAS  Google Scholar 

  • Migliorini D, Danovi D, Colombo E, Carbone R, Pelicci PG, Marine JC . (2002). Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J Biol Chem 277: 7318–7323.

    Article  CAS  Google Scholar 

  • Ohtsubo C, Shiokawa D, Kodama M, Gaiddon C, Nakagama H, Jochemsen AG et al. (2009). Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2. Cancer Sci 100: 1291–1299.

    Article  CAS  Google Scholar 

  • Okamoto K, Kashima K, Pereg Y, Ishida M, Yamazaki S, Nota A et al. (2005). DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol Cell Biol 25: 9608–9620.

    Article  CAS  Google Scholar 

  • Okamoto K, Taya Y, Nakagama H . (2009). Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Lett 583: 2710–2714.

    Article  CAS  Google Scholar 

  • Pan Y, Chen J . (2003). MDM2 promotes ubiquitination and degradation of MDMX. Mol Cell Biol 23: 5113–5121.

    Article  CAS  Google Scholar 

  • Pereg Y, Shkedy D, de Graaf P, Meulmeester E, Edelson-Averbukh M, Salek M et al. (2005). Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. Proc Natl Acad Sci USA 102: 5056–5061.

    Article  CAS  Google Scholar 

  • Perry ME, Mendrysa SM, Saucedo LJ, Tannous P, Holubar M . (2000). p76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53. J Biol Chem 275: 5733–5738.

    Article  CAS  Google Scholar 

  • Pikkarainen S, Kennedy RA, Marshall AK, Tham el L, Lay K, Kriz TA et al. (2009). Regulation of expression of the rat orthologue of mouse double minute 2 (MDM2) by H(2)O(2)-induced oxidative stress in neonatal rat cardiac myocytes. J Biol Chem 284: 27195–27210.

    Article  CAS  Google Scholar 

  • Prodosmo A, Giglio S, Moretti S, Mancin F, Barbi S, Avenia N et al. (2008). Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. J Mol Med 86: 585–596.

    Article  CAS  Google Scholar 

  • Ralhan R, Sandhya A, Meera M, Bohdan W, Nootan SK . (2000). Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer. Am J Pathol 157: 587–596.

    Article  CAS  Google Scholar 

  • Salem MM, Shalbaf M, Gibbons NC, Chavan B, Thornton JM, Schallreuter KU . (2009). Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J 23: 3790–3807.

    Article  CAS  Google Scholar 

  • Saucedo LJ, Myers CD, Perry ME . (1999). Multiple murine double minute gene 2 (MDM2) proteins are induced by ultraviolet light. J Biol Chem 274: 8161–8168.

    Article  CAS  Google Scholar 

  • Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M et al. (1996). MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 15: 5349–5357.

    Article  CAS  Google Scholar 

  • Toledo F, Wahl GM . (2007). MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int J Biochem Cell Biol 39: 1476–1482.

    Article  CAS  Google Scholar 

  • Wang YV, Wade M, Wahl GM . (2009). Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo. Cell Cycle 8: 3443–3444.

    Article  CAS  Google Scholar 

  • Wang YV, Wade M, Wong E, Li YC, Rodewald LW, Wahl GM . (2007). Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation. Proc Natl Acad Sci USA 104: 12365–12370.

    Article  CAS  Google Scholar 

  • Zhou JX, Lee CH, Qi CF, Wang H, Naghashfar Z, Abbasi S et al. (2009). IFN regulatory factor 8 regulates MDM2 in germinal center B cells. J Immunol 183: 3188–3194.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The work was supported by research grants from Associazione Italiana Ricerca sul Cancro (AIRC), Ministero della Sanità. We are grateful to Dr Lozano for Mdm2−/−p53−/−MEFs, to Dr JC Marine for Mdm4−/−Mdm2−/−p53−/−MEFs and to Dr Jochemsen for phosphorylation-defective human MDM4S403A coding plasmid. We are also especially grateful to Dr Jochemsen for critical review and helpful comments to the paper.

Author information

Author notes

  1. S Giglio and F Mancini: These authors contributed equally to this work.

Authors and Affiliations

  1. Institute of Neurobiology and Molecular Medicine, CNR/Fondazione Santa Lucia, Roma, Italy

    S Giglio, F Mancini, M Pellegrino, G Di Conza & F Moretti

  2. Institute Medical Pathology, Catholic University, Roma, Italy

    S Giglio, F Mancini & A Pontecorvi

  3. Department of Experimental-Clinical Medicine and Pharmacology, University of Messina, Messina, Italy

    G Di Conza

  4. Department of Internal Medicine, University of Perugia, Perugia, Italy

    E Puxeddu

  5. Laboratory Molecular Oncogenesis, Regina Elena Cancer Institute, Roma, Italy

    A Sacchi

Authors
  1. S Giglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Mancini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Pellegrino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Di Conza
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Puxeddu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Sacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Pontecorvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Moretti.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giglio, S., Mancini, F., Pellegrino, M. et al. Regulation of MDM4 (MDMX) function by p76MDM2: a new facet in the control of p53 activity. Oncogene 29, 5935–5945 (2010). https://doi.org/10.1038/onc.2010.324

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.324

Keywords

This article is cited by

Search

Advanced search

Quick links